Cardiotoxicity of antitumor agents
- 31 December 1984
- journal article
- review article
- Published by Elsevier in Progress in Cardiovascular Diseases
- Vol. 27 (3), 195-200
- https://doi.org/10.1016/0033-0620(84)90004-5
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Mediation of Subacute Anthracycline Cardiotoxicity in Rabbits by Cardiac Histamine ReleaseJournal of Cardiovascular Pharmacology, 1983
- Sensitivity and specificity of radionuclide ejection fractions in doxorubicin cardiotoxicityAmerican Heart Journal, 1983
- Dose-effect and structure-function relationships in doxorubicin cardiomyopathyAmerican Heart Journal, 1981
- Acute and Chronic Cardiovascular Effects of Doxorubicin in the DogJournal of Cardiovascular Pharmacology, 1980
- Anthracycline cardiotoxicity: Clinical and pathologic outcomes assessed by radionuclide ejection fractionCancer, 1980
- Selective inhibition of rat and human cardiac guanylate cyclase in vitro by doxorubicin (Adriamycin): Possible link to anthracycline cardiotoxicityJournal of Molecular and Cellular Cardiology, 1979
- Serial Assessment of Doxorubicin Cardiotoxicity with Quantitative Radionuclide AngiocardiographyNew England Journal of Medicine, 1979
- CARDIOTOXICITY OF 5-FLUOROURACILThe Lancet, 1977
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977
- Inhibition of coenzyme Q10-enzymes, succinoxidase and NADH-oxidase, by adriamycin and other quinones having antitumor activityBiochemical and Biophysical Research Communications, 1974